Advertisement

Gerinnungsphysiologische Laboranalytik

  • Michael Spannagl
  • Dirk Peetz

Zusammenfassung

Mit POCT-Systemen können die unterschiedlichen Phasen der Hämostase (primäre Hämostase, Thrombin-/Fibringenerierung, Gerinnselbildung und Fibrinolyse) gemessen werden. Dabei werden komplexe biologische Abläufe erfasst. Bei diesen Messsystem werden meist hohe Anforderungen an Schulung, Interpretation und Qualitätssicherung gestellt. Häufig sind Geräte zur patientennahen Messung von Gerinnungsglobaltests (INR, PTT, ACT) im Einsatz. Das Patientenselbstmanagement der Vitamin-K-Antagonisten mit der INR-Messung zeigt sehr gute Ergebnisse.

Literatur

  1. 1.
    Avidan MS, Alcock El, Da Fonseca JH et al. (2004) Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92: 178–186Google Scholar
  2. 2.
    Bosch YP, Ganushchak YM, de Jong DS (2006) Comparison of ACT point-of-care measurements: repeatability and agreement. Perfusion 1: 27–31Google Scholar
  3. 3.
    Calatzis A, Heesen M, Spannagl M (2003) Patientennahe Sofortdiagnostik von Hämostaseveränderungen in der Anästhesie und Intensivmedizin. Anaesthesist 52: 229–237Google Scholar
  4. 4.
    Ferring M, Reber G, de Moerloose P, Merlani P, Diby M, Ricou B (2001) Point of care and central laboratory determinations of the aPTT are not interchangeable in surgical intensive care patients. Can J Anaesth 48: 1155–1160Google Scholar
  5. 5.
    Gibbs NM (2009) Point-of-care assessment of antiplatelet agents in the perioperative period: a review. Anaesth Intensive Care 37:354–369Google Scholar
  6. 6.
    Hartert H (1948) Blutgerinnungsstudien mit der Thrombelastographie, einem neuen. Untersuchungsverfahren. Klin Wschr 26: 577–583Google Scholar
  7. 7.
    Haubelt H, Anders C, Vogt A, Hoerdt P, Seyfert UT, Hellstern P (2005) Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals. Br J Haematol 130: 759–767Google Scholar
  8. 8.
    Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK (2006) Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 4: 312–319Google Scholar
  9. 9.
    Karger R, Donner-Banzhoff N, Müller HH et al. (2007) Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis. Platelets. 18: 249–260Google Scholar
  10. 10.
    Koscielny J, Ziemer S, Radtke H et al. (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 195–204Google Scholar
  11. 11.
    Kratzer MA, Born GV (1985) Simulation of primary haemostasis in vitro. Haemostasis;15:357–362Google Scholar
  12. 12.
    Leyvi G, Shore-Lesserson L, Harrington D, Vela-Cantos F, Hossain S (2001) An investigation of a new activated clotting time »MAX-ACT« in patients undergoing extracorporeal circulation. Anesth Analg 92: 578–583Google Scholar
  13. 13.
    Luddington RJ (2005) Thromboelastography. Clin Lab Haematol 27: 81–90Google Scholar
  14. 14.
    Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J (1997) Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 11:24–28Google Scholar
  15. 15.
    Niederdöckl J, Dempfle CE, Schönherr HR, Bartsch A, Miles G, Laggner A, Pathil A. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors. Int J Lab Hematol. 2016;38:426-434Google Scholar
  16. 16.
    Nitu-Whalley IC, Lee CA, Brown SA, Riddell A, Hermans C (2003) The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand’s disease and its relationships with von Willebrand factor and the ABO blood group. Haemophilia 9: 298–302Google Scholar
  17. 17.
    Paniccia R, Priora R, Liotta AA, Abbate R (2015) Platelet function tests: a comparative review. Vasc Health Risk Manag 11:133–148Google Scholar
  18. 18.
    Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators (2011) Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097–1105Google Scholar
  19. 19.
    Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N (2009) Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 53:849–856Google Scholar
  20. 20.
    Smith JW, Steinhubl SR, Lincoff AM et al. (1999) Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 99:620–625Google Scholar
  21. 21.
    Spannagl M, Dick A, Junker R (2010) Qualitätssicherung bei POCT-Methoden in der Hämostaseologie. Hämostaseologie 30;2: 82–90Google Scholar
  22. 22.
    Spannagl M, Dick A, Junker R (2010) POCT in coagulation. Hämostaseologie 30:82–90Google Scholar
  23. 23.
    Toth O, Calatzis A, Penz S, Losonczy H, Siess W (2006) Multiplate electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781–788Google Scholar
  24. 24.
    Zucker ML (2007) The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Point of Care Coagulation Testing. Point of Care 6: 223–226Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  • Michael Spannagl
    • 1
  • Dirk Peetz
    • 2
  1. 1.Klinikum der Universität MünchenMünchenDeutschland
  2. 2.Institut für LaboratoriumsmedizinHELIOS Klinikum Berlin-BuchBerlinDeutschland

Personalised recommendations